Welcome to our dedicated page for Goodrx Holdings news (Ticker: GDRX), a resource for investors and traders seeking the latest updates and insights on Goodrx Holdings stock.
GoodRx Holdings, Inc. (NASDAQ: GDRX) is widely described as the leading platform for medication savings in the U.S., and its news flow reflects that role at the intersection of digital healthcare, pharmacy, and pharmaceutical manufacturers. Company announcements highlight new partnerships, product launches, and financial updates that shape how consumers, pharmacies, and manufacturers approach prescription affordability.
News about GoodRx often covers collaborations with major healthcare players. Examples include the RxSmartSaver program powered by GoodRx at national and regional retail pharmacies, which brings brand medication savings directly to the pharmacy counter, and an exclusive partnership with Surescripts that integrates GoodRx discounted cash prices into Script Corner, a patient experience product focused on prescription price transparency.
GoodRx also issues press releases on new consumer offerings and subscriptions. Recent updates describe GoodRx for Weight Loss, a telemedicine subscription for GLP-1 weight management treatment, and GoodRx for Hair Loss, a subscription program for men that combines virtual consultations, prescriptions for oral finasteride or oral minoxidil when appropriate, and discreet home delivery. Additional news highlights defined cash prices for medications such as Repatha, Ozempic, Wegovy, and the Wegovy pill at tens of thousands of pharmacies nationwide via GoodRx.
Investors and observers can also find earnings-related news, including quarterly financial results, guidance commentary, and participation in healthcare conferences. Together, these updates provide insight into GoodRx’s strategy across prescription transactions, subscriptions, pharma manufacturer solutions, and telehealth. For anyone tracking GDRX, this news page offers a focused view of how the company is evolving its platform, expanding partnerships, and addressing medication affordability across the U.S. healthcare system.
GoodRx (NASDAQ: GDRX) has launched a new feature called Provider Mode, designed to streamline the enrollment process for healthcare providers (HCPs) prescribing VUMERITY® (diroximel fumarate) for relapsing multiple sclerosis. This digital form helps reduce paperwork and errors, significantly speeding up patient treatment initiation. Since its rollout, Provider Mode has achieved a 90% opt-in rate from providers, with Biogen (NASDAQ: BIIB) being the first pharmaceutical partner to use this system. This collaboration aims to enhance patient care by simplifying the therapy start process.
GoodRx Holdings Inc. (GDRX) will release its Q3 2022 financial results on November 8, 2022, after U.S. market close. A conference call and webcast are scheduled for the same day at 2:00 PM PT (5:00 PM ET) to discuss these results and provide business insights. GoodRx, a digital healthcare platform, has saved consumers over $40 billion since its launch in 2011. Investors can access the live call and archived materials on the Company’s investor relations website.
GoodRx (NASDAQ: GDRX) is offering free online healthcare provider visits to Florida residents affected by Hurricane Ian until October 17, using the code FL-CARE-100. This initiative aims to ensure residents can access essential healthcare services amidst the ongoing recovery challenges. GoodRx Care allows for consultations for various conditions and medication refills, aiding those impacted by the disaster. The platform is focused on making healthcare affordable and convenient, having saved consumers over $40 billion since its inception in 2011.
GoodRx Holdings, Inc. (Nasdaq: GDRX) will present at the Goldman Sachs 2022 Communacopia + Technology Conference in San Francisco, CA, on Thursday, September 15, at 11:30 a.m. PT (2:30 p.m. ET). A live webcast will be available on the Company's Investor Relations website. GoodRx, a digital healthcare platform, has helped consumers save over $40 billion since 2011, providing affordable healthcare solutions. Archived recordings of the presentation will be accessible for at least 30 days post-conference.
Summary not available.
GoodRx (NASDAQ: GDRX) is offering free online healthcare visits for Kentucky residents affected by recent flooding using the code KY-CARE-100. Available until August 31, 2022, this service allows individuals to consult licensed medical providers for various conditions and refill medications lost during the disaster. The initiative aims to support Kentuckians struggling to access healthcare during this challenging time. GoodRx has helped consumers save over $40 billion since its inception in 2011, emphasizing its commitment to affordable healthcare.
GoodRx Holdings, Inc. (Nasdaq: GDRX) announced that its management will present virtually at the Bank of America SMID Cap Ideas Conference on August 10 at 8:20 a.m. Pacific Time. A live webcast will be accessible on the Company’s Investor Relations website, with an archived recording available for 30 days after the event. GoodRx, a leading digital healthcare platform, has helped consumers save over $40 billion since 2011 and is among the most downloaded medical apps.
GoodRx Holdings Inc. (GDRX) will release its second quarter 2022 financial results on August 8, 2022, after U.S. market close. A conference call is scheduled for the same day at 2:00 PM PT (5:00 PM ET) to discuss the results and the company’s outlook. Investors can access the call by pre-registering via a provided link. GoodRx, a leading digital healthcare platform, has saved consumers over $40 billion since 2011, highlighting its role in making healthcare affordable for Americans.
GoodRx, a digital healthcare platform, announced a strategic partnership with RxVantage to enhance provider access to pharmaceutical resources. The integration aims to streamline connections between over 700,000 healthcare providers and drug manufacturers, addressing the administrative burdens faced by providers when accessing medication information. This initiative is expected to improve patient outcomes by facilitating timely communication regarding therapies and support programs. GoodRx has saved consumers over $35 billion since its inception in 2011.
GoodRx Holdings, Inc. (GDRX) reported its first quarter 2022 financial results, showcasing its role as a top consumer-focused digital healthcare platform. The company has significantly aided Americans, delivering over $35 billion in savings since its inception in 2011. A conference call is set for May 9, 2022, at 2:00 PM PT to elaborate on the results and future business outlook. The company is committed to making healthcare affordable and accessible across the U.S., supported by its technology and highly downloaded mobile app.
FAQ
What is the current stock price of Goodrx Holdings (GDRX)?
What is the market cap of Goodrx Holdings (GDRX)?
